INTERNATIONAL JOURNAL OF LATEST TECHNOLOGY IN ENGINEERING,
MANAGEMENT & APPLIED SCIENCE (IJLTEMAS)
ISSN 2278-2540 | DOI: 10.51583/IJLTEMAS | Volume XIII, Issue IX, September 2024
www.ijltemas.in Page 121
34. Van Vuuren, S. F., Kamatou, G. P., & Viljoen, A. M. (2010). Volatile composition and antimicrobial activity of twenty
commercial frankincense essential oil samples. South African Journal of Botany, 76(4), 686-691.
35. Iram, F., Khan, S. A., & Husain, A. (2017). Phytochemistry and potential therapeutic actions of Boswellic acids: A mini-review.
Asian Pacific journal of tropical biomedicine, 7(6), 513-523.
36. Gebrehiwot, K., Muys, B., Haile, M., & Mitloehner, R. (2003). Introducing Boswellia papyrifera (Del.) Hochst and its non-
timber forest product, frankincense. International forestry review, 5(4), 348-353.
37. Niebler, J., & Buettner, A. (2016). Frankincense revisited, part I: Comparative analysis of volatiles in commercially relevant
Boswellia species. Chemistry & Biodiversity, 13(5), 613-629.
38. Miran, M., Amirshahrokhi, K., Ajanii, Y., Zadali, R., Rutter, M. W., Enayati, A., & Movahedzadeh, F. (2022). Taxonomical
investigation, chemical composition, traditional use in medicine, and pharmacological activities of Boswellia sacra flueck.
Evidence‐Based Complementary and Alternative Medicine, 2022(1), 8779676.
39. Stürner, K. H., Stellmann, J. P., Dörr, J., Paul, F., Friede, T., Schammler, S., ... & Heesen, C. (2018). A standardised
frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial). Journal of
Neurology, Neurosurgery & Psychiatry, 89(4), 330-338.
40. Lemenith, M., & Teketay, D. (2003). Frankincense and myrrh resources of Ethiopia: II. Medicinal and industrial uses. SINET:
Ethiopian Journal of Science, 26(2), 161-172.
41. Bansal, N., Mehan, S., Kalra, S., & Khanna, D. (2013). Boswellia serrata-frankincense (A Jesus Gifted Herb); an updated
pharmacological profile. Pharmacologia, 4(6), 457-463.
42. Okano, S., Honda, Y., Kodama, T., & Kimura, M. (2019). The effects of frankincense essential oil on stress in rats. Journal of
Oleo Science, 68(10), 1003-1009.
43. Cerutti‐Delasalle, C., Mehiri, M., Cagliero, C., Rubiolo, P., Bicchi, C., Meierhenrich, U. J., & Baldovini, N. (2016). The
(+)‐cis‐and (+)‐trans‐Olibanic Acids: Key Odorants of Frankincense. Angewandte Chemie, 128(44), 13923-13927.
44. Rashan, L., Hakkim, F. L., Idrees, M., Essa, M. M., Velusamy, T., Al-Baloshi, M., ... & Hasson, S. S. A. A. (2019). Boswellia
gum resin and essential oils: Potential health benefits− An evidence based review. International Journal of Nutrition,
Pharmacology, Neurological Diseases, 9(2), 53-71.
45. Thulin, M. (2020). The Genus Boswellia (Burseraceae): The Frankincense Trees. Acta Universitatis Upsaliensis.
46. Wu, Y. R., Xiong, W., Dong, Y. J., Chen, X., Zhong, Y. Y., He, X. L., ... & Zhou, Q. (2024). Chemical Constituents and
Pharmacological Properties of Frankincense: Implications for Anticancer Therapy. Chinese Journal of Integrative Medicine, 1-9.
47. Satyal, P., & Pappas, R. S. (2016). First reporting on the chemistry and biological activity of a novel Boswellia chemotype: The
methoxy alkane frankincense. Glob. J. Sci. Front. Res. B Chem, 16, 1-9.
48. Al-Salmi, F. A., Salman, N. S. S. B., Badri, N. A., Othman, F. A. A. B., & Al Salmi, S. A. A comprehensive overview of
biochemical and histological inducible alterations from frankincense aqueous extract on Wistar rats.
49. Leminih, M., & Teketay, D. (2003). Frankincense and myrrh resources of Ethiopia: I distribution, production, opportunities for
dryland development and research needs. SINET: Ethiopian Journal of Science, 26(1), 63-72.
50. Ismail, S. M., Aluru, S., Sambasivarao, K. R. S., & Matcha, B. (2014). Antimicrobial activity of frankincense of Boswellia
serrata. Int. J. Curr. Microbiol. App. Sci, 3(10), 1095-1101.
51. Khan, A. L., Al-Harrasi, A., Wang, J. P., Asaf, S., Riethoven, J. J. M., Shehzad, T., ... & Wang, X. Y. (2022). Genome structure
and evolutionary history of frankincense producing Boswellia sacra. Iscience, 25(7).
52. Sultan, F. I. (2020). Phytochemical analysis and antibacterial activities of Frankincense of Boswellia serrate. Plant Archives,
20(2), 5219-5226.
53. Shen, T., & Lou, H. X. (2008). Bioactive constituents of myrrh and frankincense, two simultaneously prescribed gum resins in
Chinese traditional medicine. Chemistry & biodiversity, 5(4), 540-553.
54. Mahdian, D., Abbaszadeh-Goudarzi, K., Raoofi, A., Dadashizadeh, G., Abroudi, M., Zarepour, E., & Hosseinzadeh, H. (2020).
Effect of Boswellia species on the metabolic syndrome: A review. Iranian Journal of Basic Medical Sciences, 23(11), 1374.
55. Almutairi, M. B. F., Alrouji, M., Almuhanna, Y., Asad, M., & Joseph, B. (2022). In-Vitro and In-Vivo Antibacterial Effects of
Frankincense Oil and Its Interaction with Some Antibiotics against Multidrug-Resistant Pathogens. Antibiotics, 11(11), 1591.
56. Moussaieff, A., & Mechoulam, R. (2009). Boswellia resin: from religious ceremonies to medical uses; a review of in-vitro, in-
vivo and clinical trials. Journal of Pharmacy and Pharmacology, 61(10), 1281-1293.
57. Huang, K., Chen, Y., Liang, K., Xu, X., Jiang, J., Liu, M., & Zhou, F. (2022). Review of the chemical composition,
pharmacological effects, pharmacokinetics, and quality control of Boswellia carterii. Evidence‐Based Complementary and
Alternative Medicine, 2022(1), 6627104.
58. Jivad, N., Rafeian, M., & Yarmohammadi, P. (2017). A Clinical Survey Efficacy Of Frankincense In Acute Ischemic Stroke.
Advances in Biosciences & Clinical Medicine, 32.
59. Su, S., Duan, J., Chen, T., Huang, X., Shang, E., Yu, L., ... & Tang, Y. (2015). Frankincense and myrrh suppress inflammation
via regulation of the metabolic profiling and the MAPK signaling pathway. Scientific reports, 5(1), 13668.
60. Efferth, T., & Greten, H. J. (2011). Anti-inflammatory and anti-cancer activity of boswellic acids from frankincense (Boswellia
serrata Roxb. et Colebr, B. carterii Birdw.). Onco Therapeutics, 2(4).